Juliano Marçal Lopes

Dr. Juliano Marçal Lopes

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LALasith Adhikari
Lasith Adhikari
TOTezcan Ozrazgat-Baslanti
Tezcan Ozrazgat-Baslanti
MRMatthew Ruppert
Matthew Ruppert
RMR W M A Madushani
R W M A Madushani
SPSrajan Paliwal
Srajan Paliwal
Azra BihoracAzra Bihorac
Azra Bihorac
Acute kidney injury (AKI) is a common complication after surgery that is associated with increased morbidity and mortality. The majority of existing perioperative AKI risk prediction models are limited in their generalizability and do not fully utilize intraoperative physiological time-series data. Thus, there is a need for intelligent, accurate, and robust systems to leverage new information as it becomes available to predict the risk of developing postoperative AKI. A retrospective single-center cohort of 2,911 adults who underwent surgery at the University of Florida Health between 2000 and 2010 was utilized for this study. Machine learning and statistical analysis techniques were used to develop perioperative models to predict the risk of developing AKI during the first three days after surgery, first seven days after surgery, and overall (after surgery during the index hospitalization). The improvement in risk prediction was examined by incorporating intraoperative physiological time-series variables. Our proposed model enriched a preoperative model that produced a probabilistic AKI risk score by integrating intraoperative statistical features through a machine learning stacking approach inside a random forest classifier. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), accuracy, and Net Reclassification Improvement (NRI). The predictive performance of the proposed model is better than the preoperative data only model. The proposed model had an AUC of 0.86 (accuracy of 0.78) for the seven-day AKI outcome, while the preoperative model had an AUC of 0.84 (accuracy of 0.76). Furthermore, by integrating intraoperative features, the algorithm was able to reclassify 40% of the false negative patients from the preoperative model. The NRI for each outcome was AKI at three days (8%), seven days (7%), and overall (4%). Postoperative AKI prediction was improved with high sensitivity and specificity through a machine learning approach that dynamically incorporated intraoperative data.

30 April 2022 in Annals of Operations Research
Verified
Journal Article
Closed access
PDF file
JLJuliano Marçal Lopes
Juliano Marçal Lopes
CMCoralys Colon Morales
Coralys Colon Morales
MAMichelle Alvarado
Michelle Alvarado
VMVidal Augusto Z. C. Melo
Vidal Augusto Z. C. Melo
LPLeonardo Batista Paiva
Leonardo Batista Paiva
Panos M. PardalosPanos M. Pardalos
Panos M. Pardalos

11 March 2019 in IEEE Technology and Society Magazine
Verified
Journal Article
Closed access
GGGustavo Gil Gasiola
Gustavo Gil Gasiola
JLJuliano Marçal Lopes
Juliano Marçal Lopes
AJAugusto Ferreira Brandao Junior
Augusto Ferreira Brandao Junior
EDEduardo Mario Dias
Eduardo Mario Dias

12 January 2023 in Economies
Verified
Journal Article
Open access
PDF file
Patricia Véras MarronePatricia Véras Marrone
Patricia Véras Marrone
FMFabio Rampazzo Mathias
Fabio Rampazzo Mathias
WBWanderley Bernardo
Wanderley Bernardo
MOMarina Orlandini
Marina Orlandini
MSMaria Carolina Andrade Serafim
Maria Carolina Andrade Serafim
EDEduardo Mario Dias
Eduardo Mario Dias
(1) Background: Any disturbance in the pharmaceutical supply chain (PSC) can disrupt the supply of medicines and affect the efficiency of health systems. Due to shortages in the global pharma supply chain over the past few years and the complex nature of free trade and its limitations when confronted by a major global health and humanitarian crisis, many countries have taken steps to mitigate the risks of disruption, including, for example, recommending the adoption of a plus one diversification approach, increasing safety stock, and nationalizing the medical supply chains. (2) Objective: To scope findings in the academic literature related to decision criteria to guide national policy decisions for the “Partial Nationalization of Pharmaceutical Supply Chain” (PNPSC) from the viewpoints of the three main stakeholders: industry, payers (government and health insurance), and patients. (3) Methods: These consist of a scoping review of the peer-reviewed literature. (4) Results: A total of 115 studies were included. For local manufacturing decisions, five criteria and 15 sub-criteria were identified. Weighting, decision-making, risk assessment, and forecasting were the main data analysis tools applied; (5) Conclusions: The findings could serve as a baseline for constructing PNPSC frameworks after careful adaptation to the local context.

6 September 2022
Verified
Thesis
Open access
PDF file
JLJuliano Marçal Lopes
Juliano Marçal Lopes
Advances in research and development have resulted in the emergence of many new vaccines in recent decades. However, the distribution of vaccines and the fight against vaccine-preventable diseases is still...